What National Labs does

National Labs is a specialty clinical toxicology laboratory founded in 2013 and headquartered in Hayward, California, serving clinical and institutional buyers across pain management, addiction/substance abuse treatment, mental health, transplant programs, work comp, community health, and primary care. The company runs high-complexity confirmatory drug and alcohol testing anchored by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS/MS) on automated robotic specimen preparation systems, with a stated patented methodology, customizable dynamic reference ranges, and an in-house clinical toxicology consultation team. Its flagship product, SpotCheck Plus, is positioned as the first all-in-one dried blood spot (DBS) kit combining PEth alcohol biomarker analysis (tracking up to 30 days of alcohol use) with a 65+ analyte toxicology panel from a single finger-prick, returning results in 24–36 hours with 95% of LCMS specimens resulted within 48 hours of receipt.

The company is founder-owned and bootstrapped under Ron Perkes, who established National Labs in 2013 to support medication compliance and substance abuse testing in mental health populations. Go-to-market is sales-led and multi-channel: direct demos with complimentary SpotCheck Intro Kits, an in-house phone-based inside sales team (1-800-800-6060), enterprise-style field sales to counties, hospitals, schools, long-term care, and correctional/transplant programs, plus a self-serve web portal with Chain of Custody, Single Sign-On, EMR interfacing, and randomized scheduling via Interactive Voice Response. Pricing is quote-based institutional contract pricing and insurance-reimbursed per-specimen billing; the company holds CLIA high-complexity certification, CAP Accreditation, and California Department of Public Health Methadone Certification. A legacy COVID-19 RT-PCR testing service under EUA, telehealth remote drug testing for Assisted Outpatient Treatment programs, and educational clinical resources round out the offering, and the 2025 SpotCheck Plus rollout is explicitly aligned with California Proposition 1 and DHCS behavioral health priorities.

Name

National Labs

Legal name

National Labs, Inc.

Website

https://nationallabs.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

National Labs is a Hayward, California–based specialty clinical toxicology laboratory offering high-complexity LC-MS/MS/MS drug and alcohol testing, anchored by its SpotCheck Plus dried blood spot kit, to clinical and institutional buyers in mental health, addiction, pain, transplant, and behavioral health programs.

Ownership category

akta.pro rank

Product category

Clinical Toxicology Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

akta.pro secondary industry

Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA)

Keywords

• Toxicology laboratory services
• Dried blood spot testing
• Medication compliance monitoring
• Substance abuse testing
• PEth alcohol biomarker

Headquarters

HQ city

Hayward

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Lab testing services (per-specimen billing): Revenue generated from quantitative confirmatory toxicology and SpotCheck Plus DBS tests billed to insurance providers, patients, and institutional clients. Acceptance of all insurance providers with no cost to patients (for COVID-19 era testing); competitive contract pricing for institutional clients; in-house billing department handles claims and patient billing.
2. Remote Testing / Telehealth Drug Testing Programs: Revenue from Remote Testing Program and Assisted Outpatient Treatment (AOT) program enabling real-time monitoring of patient compliance during Telehealth visits with oral fluid collection and SpotCheck Plus testing.
3. Professional services and consultation: Revenue (and customer-support services) from clinical toxicology consultation, in-office staff training, regulatory/best-practices consultation, custom test regimen design, and toxicology consultation on report review.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

National Labs is a specialty clinical laboratory that provides confirmatory toxicology and medication compliance testing for pain management, addiction, mental health, transplant, and other clinical programs. Its core offerings include high-complexity LC-MS/MS/MS toxicology testing across urine, oral fluid, and dried blood spot specimens, and its flagship SpotCheck Plus dried blood spot test that combines PEth alcohol biomarker analysis with a 65+ analyte panel from a single finger-prick, returned in 24-36 hours. The lab wraps these tests with an enhanced 360 web portal, EMR interfacing, randomized scheduling, Chain of Custody, and remote telehealth testing support.

Product overview

National Labs is a specialty clinical laboratory based in Hayward, California offering drug testing and medication monitoring services anchored by two product lines: (1) SpotCheck Plus, the company's flagship dried blood spot (DBS) test that combines PEth alcohol biomarker analysis with a 65+ analyte toxicology panel in a single painless finger-prick kit returning results in 24–36 hours, and (2) the broader Toxicology Testing Services built on Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS/MS) across urine, oral fluid, and dried blood spot specimens. These offerings are wrapped by the Clinical Services / Clinic Value platform — an end-to-end program that adds an enhanced 360 web portal, custom data analytics, randomized test scheduling via Interactive Voice Response, Chain of Custody and Single Sign-On (SSO), EMR interfacing, and Telehealth Remote Drug Testing for AOT programs. Supporting modules include the COVID-19 Testing Services (RT-PCR under EUA), the Clinical Resources knowledge hub, and National Labs' patented Methodology framework (with robotic specimen preparation and in-house PhD toxicology support) that powers all of the above. The company holds CLIA high-complexity certification, CAP Accreditation, and California Methadone Certification, positioning itself as a specialty lab leader for pain management, addiction/substance treatment, mental health, work comp, community health, and primary care.

Differentiator

Problem solved

Functional benefit

Brands

• SpotCheck Plus: National Labs' all-in-one dried blood spot (DBS) testing solution that combines PEth alcohol biomarker testing with comprehensive toxicology screening (65+ analytes including drugs, medications, fentanyl analogs, xylazine, and mental health prescriptions) via a simple finger-prick collection kit. Used across clinical, mobile, telehealth, transplant, and substance abuse program settings.

Products and services

• SpotCheck Plus (Dried Blood Spot Testing) National Labs' flagship dried blood spot (DBS) test that combines PEth alcohol biomarker analysis with a 65+ analyte toxicology panel in a single painless finger-prick kit. Detects drugs, medications, fentanyl analogs, xylazine, and designer drugs, tracks up to 30 days of alcohol use via PEth, and returns results in 24-36 hours via LCMS analysis. Used across clinical, mobile, telehealth, transplant, and substance abuse program settings.
• Toxicology Testing Services High-complexity confirmation toxicology testing using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS/MS) across urine, oral fluid, and dried blood spot specimen types. Provides a comprehensive drug class menu (Alcohol Biomarkers, Alkaloids, Amphetamines, Antidepressants, Antipsychotics, Fentanyl Analogs, Benzodiazepines, Opiates, etc.) with customized panels, synthetic urine detection, and 95% of LCMS results reported within 48 hours. Serves pain management, addiction, mental health, work comp, community health, and primary care programs.
• Clinical Services (Clinic Value) End-to-end clinical support program that wraps around the lab's toxicology and SpotCheck Plus testing, providing enhanced web portal ordering/reporting (360 online reporting), custom data analytics, randomized test scheduling via Interactive Voice Response, Chain of Custody and Single Sign-On (SSO) services, remote drug testing for telehealth and Assisted Outpatient Treatment (AOT) programs, EMR interfacing, multi-tier account support, and ongoing industry education.
• Telehealth Remote Drug Testing Remote testing program enabling real-time patient compliance monitoring during Telehealth visits, using oral fluid collection and SpotCheck Plus dried blood spot testing. Designed to support Assisted Outpatient Treatment (AOT) programs and telehealth providers.
• COVID-19 Testing Services Full-service COVID-19 testing package including front-end specimen collection (anterior nares, nasopharyngeal, saliva) and back-end RT-PCR testing under EUA. Tests for 3 genetic markers to capture known COVID variants with automated specimen processing and average turnaround under 24 hours post-specimen receipt; results delivered via web portal with optional EMR integration. Acceptance of all insurance providers with no cost to patients.
• National Labs Methodology Patented methodology and experience-driven best practices framework that underpins the lab's testing workflows, combining state-of-the-art analyzers, robotic specimen preparation (reducing errors and speeding delivery), customizable dynamic reference ranges and cutoffs, in-house clinical toxicology assistance, in-office staff training, and regulatory consultation.

Quantifiable outcome

• 1,635,044 specimens reported cumulatively
• +5 more outcomes

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Four partnerships are on record, tiered reference / informational resource, reference resource for peth education and regulatory / certification authority.

• Substance Abuse and Mental Health Services Administration (SAMHSA)reference / informational resourceOthersSAMHSA is referenced on National Labs' resources and homepage as a public-health information source for behavioral health and substance abuse; no commercial partnership terms are described. SAMHSA's stated mission is to reduce the impact of substance abuse and mental illness on America's communities.
• American Chronic Pain Association (ACPA)reference / informational resourceOthersACPA is referenced on National Labs' resources and homepage as a patient-education source for chronic pain and medications; no commercial partnership terms are described.
• National Institute on Alcohol Abuse and Alcoholism (NIAAA)reference resource for peth educationOthersNIAAA is linked from the SpotCheck Plus PEth Resources section to provide clinical education on drinking levels and PEth biomarker interpretation.
• California Department of Public Health (CDPH)regulatory / certification authorityOthersNational Labs holds Methadone Certification issued by the California Department of Public Health, which is required to provide methadone-related testing services in California.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Aegis Sciences Corporation: Specialty clinical laboratory focused on toxicology and medication monitoring for pain management, addiction treatment, and behavioral health — directly overlapping with National Labs' core customer base and LC-MS/MS confirmation methodology.
• Omega Laboratories: Specialty toxicology lab with alternative-specimen expertise (hair and nails) for drug and alcohol testing — directly comparable as a specialty toxicology competitor targeting substance-use and workplace testing markets.
• United States Drug Testing Laboratories (USDTL): Specialty toxicology laboratory offering alcohol biomarker (PEth/EtG/FAEE) and substance abuse testing using alternative specimens — directly comparable in PEth alcohol biomarker expertise that anchors National Labs' SpotCheck Plus product.
• Psychemedics Corporation: Specialty laboratory focused on hair-based drug and alcohol testing for workplace, forensic, and clinical use — comparable as an alternative-specimen specialty toxicology competitor to National Labs' DBS-based SpotCheck Plus approach.
• Precision Diagnostics: Specialty clinical laboratory offering toxicology, medication monitoring, and customized drug testing panels to pain management and addiction treatment providers — comparable in customer base and per-specimen billing model.
• Millennium Health: Specialty toxicology lab offering urine drug testing, oral fluid testing, and medication monitoring via LC-MS/MS for substance use disorder and pain management — directly comparable in technology stack and clinical specialty focus.
• Cordant Health Solutions: Specialty toxicology and behavioral health lab providing medication monitoring, oral fluid, and remote testing programs including AOT — overlapping with National Labs' clinical services, telehealth offerings, and behavioral health vertical.

Broad incumbents

• Quest Diagnostics: Largest U.S. clinical reference laboratory offering broad toxicology, drug testing, and behavioral health testing services with national insurance contracts — overlapping in toxicology but at vastly larger scale and broader menu.
• Laboratory Corporation of America (Labcorp): Major U.S. clinical reference laboratory with extensive toxicology, pain management, and substance abuse testing menus — overlapping with National Labs but operating at national scale across all healthcare segments.

Emerging players

• Confirm BioSciences: Drug and alcohol testing company offering point-of-care and lab-based toxicology including dried urine and oral fluid products — comparable as a smaller emerging competitor in alternative-specimen drug testing markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Labs